Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-022446

General Counsel sold 662 shares at $3.01 ($1,995)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-19 Sale : show line 1 in the form −662 $3.01 $1,995 677,977 D
Open-market sales · 662 sh · avg $3.01 · $1,995
Loading xslF345X06/form4.xml…